The Real ROI of Preventing Duplicate Subjects in Clinical Trials
When a clinical trial misses its primary endpoint, the root cause is rarely just the science — more often, it’s hidden threats to the data itself. One of the most overlooked risks is the presence of duplicate research subjects or professional research subjects who enroll in multiple studies or across multiple sites, undermining results and
Verified Clinical Trials Expands in Japan to Prevent Duplicate and Professional Patients in Clinical Trials
Verified Clinical Trials (VCT), the world’s largest research subject database registry, has expanded operations in Japan through a collaboration with Medical Revolutions Japan (MRJ) and the Japan Association of Contract Institutes for Clinical Pharmacology (JACIC). This partnership helps address the growing global challenge of duplicate subjects in clinical trials and professional patients, which can undermine
Verified Clinical Trials Attending The American Diabetes Association Meeting: Safeguarding Duplicate Subjects In Obesity, Diabetes, And GLP-1 Clinical Trials
Verified Clinical Trials (VCT) is proud to announce our participation at the upcoming American Diabetes Association (ADA) annual meeting. As clinical research in diabetes, obesity, and GLP-1 therapies continues to expand at a record pace, VCT remains committed to delivering innovative solutions that safeguard data integrity, improve participant safety, and optimize trial outcomes by preventing
The Rise of Professional Patients in GLP-1 Clinical Trials: A Growing Threat to Data Integrity and Safety
The race to develop and commercialize GLP-1-based therapies for obesity and diabetes has created unprecedented momentum in clinical research. Dozens of sponsors and CROs are simultaneously conducting trials—often in overlapping geographic regions—with many vying for access to the same pool of patients. While this represents exciting progress in metabolic disease treatment, it also presents a
How Does Verified Clinical Trials (VCT) Protect Clinical Trials From Duplicate Research Subjects?
https://healthtechcurated.com/regulatory-and-compliance/how-does-vct-protect-clinical-trials-from-duplicate-subjects/ In the complex realm of clinical trials, preventing the enrollment of duplicate and professional research subjects is critical for maintaining data integrity and ensuring participant safety. As trials expand with overlapping indications and global participation, the risk of unethical subject enrollment increases. These duplicate reseaerch subjects, who join multiple studies without observing necessary washout
The Hidden Costs of Duplicate Research Subjects in Clinical Trials — and How Verified Clinical Trials Delivers Cross-Sponsor, Cross-Study Protections
Detecting and preventing protocol violations before they ever happen. In today’s complex clinical trial landscape, one issue continues to fly under the radar—duplicate research subjects and professional research subjects. These individuals enroll in multiple trials simultaneously or too close together, often crossing therapeutic areas, sponsors, and trial phases. Left unchecked, these subjects introduce significant risk
